Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 70.2% of AbbVie shares are […]
Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) shot up 23.3% during mid-day trading on Wednesday . The company traded as high as C$64.90 and last traded at C$64.90. 1,000 shares changed hands during trading, an increase of 150% from the average session volume of 400 shares. The stock had previously closed at C$52.65. Cosmo Pharmaceuticals […]
Shares of Cosmo Pharmaceuticals (OTC:CMOPF – Get Rating) were down 10.5% during mid-day trading on Tuesday . The stock traded as low as C$55.75 and last traded at C$55.75. Approximately 500 shares traded hands during mid-day trading, an increase of 25% from the average daily volume of 400 shares. The stock had previously closed at […]